缺血性中风患者抗β_2 GP1抗体的检测及临床意义  

The Detection and Significance of Anti-β_2GP1 antibodies in sera of The Patients with Ischemic Stroke

作　　者：杨光照[1] 汪宇 朱天义[1] 

机构地区：[1]辽宁中医药大学研究生院,110024 [2]解放军第四六三医院

出　　处：《中国医学创新》2009年第20期76-77,共2页Medical Innovation of China

摘　　要：目的研究缺血性中风患者抗β_2GP1抗体血清水平,探讨抗磷脂抗体与缺血性中风的相关性,揭示抗β_2GP1抗体的检测在临床上应用的意义。方法检测了51例缺血性中风及40例无血栓疾患的对照组血清中的抗心磷脂抗体、抗β_2GP1抗体。结果抗β_2GP1在抗体在缺血性中风组及对照组之间有显著性差异。结论抗β_2GP1抗体可能为引起患者缺血性中风的病因之一。Objective To investigate the relationship of anti - β2 GP1 antibodies in sera of the patients with Ischeic Stroke, and the significance of anti - β2 GP1 antibodies in patients with Ischemic Stroke. Methods the anti - β2 GP1 and anticardiolipin antibodies were tested in 51 patients with cerebral infarction and 40 normal controls. Results There is significance difference between Isebemic Stroke group and control group. Conclusion The results indicated that the anti - β2GP1 may play an role in pathogenesis of cerebral infarction.

关 键 词：抗β2GP1抗体 缺血性中风 

分 类 号：R255.2[医药卫生—中医内科学]